An electrophysiological analysis of hallucinogens.
D000323:Adrenochrome / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D002540:Cerebral Cortex / Q000378:metabolism / Q000502:physiology; D002704:Chlorates / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004594:Electrophysiology; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D007501:Iron / Q000494:pharmacology; D007773:Lactates / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009711:Nucleotides / Q000378:metabolism; D010627:Phenethylamines / Q000494:pharmacology; D051381:Rats; D014363:Tryptamines / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology
D002704:Chlorates; D006213:Hallucinogens; D007773:Lactates; D008781:Methyltyrosines; D009711:Nucleotides; D010627:Phenethylamines; D014363:Tryptamines; D000323:Adrenochrome; D003300:Copper; D008238:Lysergic Acid Diethylamide; D007501:Iron; D015032:Zinc; D003913:Dextroamphetamine